Description
LuciErlo 150mg is a prescription tablet containing erlotinib, an EGFR tyrosine kinase inhibitor used for metastatic non small cell lung cancer (NSCLC) with EGFR exon 19 deletions or exon 21 L858R mutations, and advanced pancreatic cancer with gemcitabine. It must be used under the supervision of a qualified doctor.
What Is LuciErlo 150mg Used For?
Erlotinib is used for metastatic non small cell lung cancer (NSCLC) with EGFR exon 19 deletions or exon 21 L858R mutations, and advanced pancreatic cancer with gemcitabine. The US FDA approved erlotinib (Tarceva) for metastatic NSCLC with EGFR exon 19 deletions or exon 21 L858R mutations and, with gemcitabine, for locally advanced, unresectable or metastatic pancreatic cancer. Your doctor decides whether it is suitable for you.
How Does Erlotinib Work?
It blocks the EGFR protein, which drives growth in these cancers.
Strength and Dosage
LuciErlo 150mg contains 150 mg of erlotinib per tablet. The dose, schedule and length of treatment depend on your condition, your other medicines and your test results, and your doctor sets them. Never change or stop your dose without medical advice.
Common Side Effects
Side effects reported with erlotinib include rash, diarrhea, loss of appetite, fatigue, shortness of breath, cough, nausea and vomiting. Contact your doctor early if any of these become severe or do not settle.
Important Safety Information
It can cause lung inflammation, liver and kidney problems, and stomach or bowel perforation. Smoking lowers its blood levels. Tell your doctor about all medicines and supplements you take, your health conditions, and any plan for pregnancy or breastfeeding before you start. Store in the original pack, away from heat, moisture and children.
Product Details
| Product | LuciErlo 150mg |
| Active ingredient | Erlotinib 150 mg |
| Drug class | EGFR tyrosine kinase inhibitor |
| Form | Oral tablet |
| Manufacturer | Lucius Pharmaceuticals |
| Pack size | As stated on the pack |
| Prescription | Required |
Frequently Asked Questions
What is LuciErlo 150mg?
LuciErlo 150mg is a prescription tablet containing erlotinib, an EGFR tyrosine kinase inhibitor used for EGFR mutated lung cancer and pancreatic cancer.
What is erlotinib used for?
Erlotinib is used for metastatic non small cell lung cancer (NSCLC) with EGFR exon 19 deletions or exon 21 L858R mutations, and advanced pancreatic cancer with gemcitabine.
Is a prescription needed for LuciErlo 150mg?
Yes. A valid prescription from a qualified doctor is required. Share it on chat through the Order Now button and our pharmacy team will guide you on the next steps.
What are the common side effects of erlotinib?
Common side effects include rash, diarrhea, loss of appetite, fatigue, shortness of breath, cough, nausea and vomiting. Contact your doctor if any side effect becomes severe or does not settle.
How can I get the price of LuciErlo 150mg?
Tap the Order Now button on this page and send your prescription on chat. Our pharmacy team will reply with today’s price, stock availability and delivery details.
Questions about this product? Contact our pharmacy team or visit our online pharmacy for more medicines.
Reviews
There are no reviews yet.